Gillian Vandekerkhove

10PUBLICATIONS
54CO-AUTHORS
Molecular targetsDecision makingPredictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 27, 2026
Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancer.

David C Müller, Andrew J Murtha, Jack V W Bacon

|Jun 20, 2025
ERBB2/HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial Cancer.

Gillian Vandekerkhove, Andrew J Murtha, David C Müller

|May 15, 2025
Factors Affecting Genomic Testing in Prostate Cancer: Results From the Decision-Making, Experience, and Confidence In Determining Genomic Evaluation (DECIDE) Survey.

Rhonda L Bitting, Christopher McNair, Alexander W Wyatt

|Dec 09, 2024
Plasma Cell-Free DNA Chromatin Immunoprecipitation Profiling Depicts Phenotypic and Clinical Heterogeneity in Advanced Prostate Cancer.

Joonatan Sipola, Aslı D Munzur, Edmond M Kwan

|Mar 28, 2024
Toward Informed Selection and Interpretation of Clinical Genomic Tests in Prostate Cancer.

Gillian Vandekerkhove, Veda N Giri, Susan Halabi

|Jan 04, 2024
Multiregion sampling of de novo metastatic prostate cancer reveals complex polyclonality and augments clinical genotyping.

Evan W Warner, Kim Van der Eecken, Andrew J Murtha

Pageof 2

Frequent Collaborators

9 joint publications

Alexander W Wyatt

5 joint publications

Bernhard J Eigl

5 joint publications

Cameron Herberts

4 joint publications

Gang Wang